Literature DB >> 12484569

Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.

Kazuma Kaneko1, Kunihiro Yoshida, Kunimasa Arima, Shinji Ohara, Hiroaki Miyajima, Takeo Kato, Michiya Ohta, Shu-ich Ikeda.   

Abstract

Aceruloplasminemia is an interesting disease, the study of which helps elucidate how iron-induced oxidative stress is involved in neuronal cell death. In order to study the neuropathological characteristics associated with oxidative stress, we scrutinized the brains of 5 patients with aceruloplasminemia histopathologically and immunohistochemically. The pathological findings were essentially similar in all patients. In the frontal cortices, iron deposition and neuronal cell loss were trivial, but in the basal ganglia (especially in the caudate nucleus and putamen), severe iron overload and extensive neuronal loss were noted. Iron deposition was more prominent in the astrocytes than in the neurons in both regions. 4-hydroxynonenal (HNE), one of the most physiologically active lipid peroxides, was strongly detected on neurons and astrocytes by immunostaining. Markedly deformed astrocytes were observed in the striatum. These astrocytes were similar to Alzheimer type 1 astrocytes. Globular structures were seen in proportion to the degree of iron deposition. They clearly reacted with anti-glial fibrillary acidic protein (GFAP) and anti-S-100 antibodies and contained glial fibril-like filaments, but showed no or only faint immunoreactivity to antibodies for neuronal marker proteins, such as neurofilament and synaptophysin. Therefore, the globular structures presumably originated from astrocytes. The structures also reacted positively to anti-HNE and anti-ubiquitin antibodies. We conclude that astrocytic deformities and globular structures are characteristic neuropathological features of aceruloplasminemia and are closely linked to iron overload and subsequent oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484569     DOI: 10.1093/jnen/61.12.1069

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  17 in total

Review 1.  The neuropathology of neurodegeneration with brain iron accumulation.

Authors:  Michael C Kruer
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

2.  Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2.

Authors:  Paul T Kotzbauer; Adam C Truax; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

3.  Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia.

Authors:  Satoshi Kono; Hitoshi Suzuki; Toshiaki Oda; Hiroaki Miyajima; Yoshitomo Takahashi; Kentaro Shirakawa; Kuniko Ishikawa; Masatoshi Kitagawa
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Cell Mol Life Sci       Date:  2014-10-30       Impact factor: 9.261

Review 5.  Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders.

Authors:  Eric Mills; Xian-Ping Dong; Fudi Wang; Haoxing Xu
Journal:  Future Med Chem       Date:  2010-01       Impact factor: 3.808

6.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 7.  The pivotal role of astrocytes in the metabolism of iron in the brain.

Authors:  Ralf Dringen; Glenda M Bishop; Maico Koeppe; Theresa N Dang; Stephen R Robinson
Journal:  Neurochem Res       Date:  2007-06-06       Impact factor: 3.996

8.  Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe.

Authors:  Jaya P Gnana-Prakasam; Pamela M Martin; Barbara A Mysona; Penny Roon; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2008-04-01       Impact factor: 3.857

9.  Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Authors:  Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

10.  Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity.

Authors:  Akiyo Hineno; Kazuma Kaneko; Kunihiro Yoshida; Shu-ichi Ikeda
Journal:  Neurochem Res       Date:  2011-06-26       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.